FDA Approves Vepdegestrant for ER+/HER2– Advanced Breast Cancer With an ESR1 Mutation
by Angela | May 27, 2026
Recap: Dana Farber Inflammatory Breast Cancer Program 8th Annual Patient Forum
by Trish Vickery | May 27, 2026
SABCS: The Whys and Hows of Clinical Trials for Inflammatory Breast Cancer (IBC) Patients
by Alisa | Mar 1, 2026
Showing Up Anyway: A Season of Conferences, Connection and Possibility
by Danielle Cameron | Nov 28, 2025
An Inflammatory Breast Cancer Milestone in Coding, But Limited Impact on Diagnosis and Treatment
by Rachel Ford | Nov 26, 2025
What to watch for regarding recurrence.
by Terry Arnold | May 24, 2024
Realistically Optimistic vs Toxic Positivity
by Clare | May 24, 2024
